Anonymous ID: f136fc Aug. 16, 2024, 7:31 a.m. No.21422245   🗄️.is 🔗kun   >>2250 >>5199

>>21416446

>DA remains ANC’s ‘guest in the GNU, not its coalition partner’: Mokonyane lashes out at Zille

 

>this is not a government of national unity because a GNU would bring all parties together, including the EFF and the MK party, which it did not

 

“GNU talks were on a knife-edge — Alan Winde on how Floyd Shivambu ‘saved South Africa’”

 

https://www.dailymaverick.co.za/article/2024-08-13-gnu-talks-were-on-a-knife-edge-alan-winde-on-how-floyd-shivambu-saved-south-africa/

13 Aug 2024

 

Describing the formation of the new government, Alan Winde, Western Cape premier and a member of the Democratic Alliance’s negotiating team in the post-election period, said the EFF and MK party were inadvertently forcing the GNU to work.

 

lan Winde, one of the Democratic Alliance (DA) negotiators for the Government of National Unity (GNU), has repeated DA Federal Council Chairperson Helen Zille’s claim that EFF Deputy President Floyd Shivambu “saved South Africa” when he called for a caucus break during the first sitting of the new National Assembly, which allowed the DA and the African National Congress (ANC) to sign a coalition agreement.

 

Winde, who in June was sworn in as Western Cape premier for a second term, addressed the Cape Town Press Club on Tuesday about the GNU and coalitions.

 

He said he was asked by DA leader John Steenhuisen to be part of the coalition negotiations alongside party veterans including Zille and Siviwe Gwarube, who is now the basic education minister.

Anonymous ID: f136fc Aug. 16, 2024, 7:33 a.m. No.21422250   🗄️.is 🔗kun   >>5199 >>5305 >>5327

>>21415804

>MK party replaces 18 MPs

 

>>21422245

>GNU talks were on a knife-edge — Alan Winde on how Floyd Shivambu ‘saved South Africa’

 

“WATCH | Floyd Shivambu dumps EFF for MK Party”

 

https://youtu.be/i-j4uRjY5Hg

Aug 15, 2024

 

https://www.ewn.co.za/2024/08/15/manyi-believes-mk-party-better-equipped-to-recapture-the-country

15 August 2024 | 11:48

 

Former Economic Freedom Fighters (EFF) member of Parliament Mzwanele Manyi says the newly formed Umkhonto Wesizwe (MK) Party is better suited to recapture the country from what he describes as "imperialists".

 

Manyi and EFF deputy president Floyd Shivambu announced their resignation from the EFF earlier on Thursday, as they’ve decided to join the MK Party.

 

He believes former president Jacob Zuma’s party is more equipped to implement land expropriation without compensation, and policies similar to those of the EFF.

 

When Manyi left the African Transformation Movement (ATM) to join the red berets in May last year, he praised the EFF as a well-oiled machine capable of bringing about transformation.

 

But having now left the EFF to join the MK Party, he has cited the same reason for his departure from the red berets.

 

"Exactly what I said about the EFF, multiply that by two with the MK Party. For all those reasons, MK Party is head and shoulders in terms of state of readiness to take over the country. You could see that this is a serious party with momentum."

 

Shivambu, who also announced his departure from the EFF, refused to disclose what influenced his crossover to the MK Party.

Anonymous ID: f136fc Aug. 16, 2024, 7:38 a.m. No.21422270   🗄️.is 🔗kun   >>2276 >>2304 >>2340 >>7168 >>7508

>>21398994

>Jeremy Farrar, Wellcome’s Director, says: "Improving health for everyone is something no one nation, organisation or sector can do alone. It requires strong leadership and partnership across borders and sectors. We look forward to working with WHO and all its partners in a more formal capacity towards shared goals in pressing areas such as universal health care, drug-resistant infections, climate change and health and being better prepared for inevitable epidemics."

 

>Over the past three years, we have provided more than $8m in funding to WHO, supporting work such as the successful Ebola vaccine trials in Guinea

 

>>21399001

>The Wellcome Trust’s director, Sir Jeremy Farrar, is to take up the role of chief scientist at the World Health Organization next year.

 

Jeremy Farrar “Fighting pandemics should be funded 'like the military'”

 

https://www.wired.com/story/pandemic-threat-wellcome-trust-zika-ebola/

Apr 13, 2016 10:44 AM

 

Governments around the world need to invest in defending against pandemics such as Ebola and Zika in the same way they invest in the military, says the head of biomedical research charity the Wellcome Trust. "We spend gazillions to defend ourselves from military attacks, but from the beginning of the twentieth century far more people have died from infection. We are hugely vulnerable from a public health perspective," explains Jeremy Farrar, an expert on infectious diseases.

 

Funding such defences cannot be left in the hands of private companies, he argues, just as we don't expect the free market to fund aircraft carriers. "This is public health. Private pharmaceutical companies will make – quite rightly – decisions based on potential commercial return. This has to be incentivised by governments, taxpayers and philanthropy, then industry has to be persuaded that it's in their interest. Otherwise we are leaving a potentially disastrous situation in the hands of the marketplace."

 

Farrar, who is speaking at WIRED Health on 29 April, described sudden outbreaks of diseases with no known vaccines or treatments as the new normal.

 

"We've had Ebola for the last two to three years, now Zika. Since 1998 I've been involved in about eight major epidemics including SARS and bird flu. This is the new world. These are not rare events," Farrar explains.

 

Diseases are more likely to spread these days because of a number of factors. Firstly, the world is more connected, which means people travel more frequently. Secondly, increasingly dense populations mean more interactions between humans and animals, where most diseases originate. Climate change also plays a role, with rising temperatures and humidity providing the perfect breeding ground for disease carriers. "With no drugs, no vaccines and no diagnostic tests, an outbreak goes from being a relatively small affair to 30,000 people," he adds, referring to Ebola in West Africa, which quickly claimed more than 11,300 lives.

 

Beyond the human cost, there is a massive financial cost to epidemics and pandemics, estimated at $60 billion (£42.17 billion) annually. Many of these costs fall on the private sector, through increased insurance claims and a fall in tourism. "The impacts on societies if we don't get prepared in terms of business disruption and economic loss, are huge," Farrar says.

Anonymous ID: f136fc Aug. 16, 2024, 7:40 a.m. No.21422273   🗄️.is 🔗kun   >>2276 >>5199 >>5762 >>2802

“Africa CDC Declares Mpox A Public Health Emergency of Continental Security, Mobilizing Resources Across the Continent”

 

https://africacdc.org/news-item/africa-cdc-declares-mpox-a-public-health-emergency-of-continental-security-mobilizing-resources-across-the-continent/

 

Addis Ababa, Ethiopia, 13 Aug 2024 – The Africa Centres for Disease Control and Prevention (Africa CDC) has officially declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.

 

This declaration, under Article 3, Paragraph F of the Africa CDC Statutes, empowers the organization to lead and coordinate responses to significant health emergencies. The statute mandates Africa CDC to “coordinate and support Member States in health emergency responses, particularly those declared PHECS or Public Health Emergency of International Concern (PHEIC), as well as health promotion and disease prevention through health systems strengthening, addressing communicable and non-communicable diseases, environmental health, and Neglected Tropical Diseases.”

 

The declaration will enable the mobilization of resources across affected countries, unlocking essential funding, strengthening Risk Communication and Community Engagement (RCCE), boosting surveillance and laboratory testing efforts, and enhancing human resource capacities to respond effectively to Mpox through a One Health approach.

 

Africa CDC Director General Dr. Jean Kaseya emphasized the urgency of swift and decisive action: “Today, we declare this PHECS to mobilize our institutions, our collective will, and our resources to act—swiftly and decisively. This empowers us to forge new partnerships, strengthen our health systems, educate our communities, and deliver life-saving interventions where they are needed most. There is no need for travel restrictions at this time.”

 

https://africacdc.org/people/dr-jean-kaseya/

 

H.E Dr. Jean Kaseya was appointed Director-General of the Africa Centres for Disease Control and Prevention (Africa-CDC) during the thirty-sixth African Union Summit of Heads of State and Government in February 2023.

 

Before assuming his role as Director-General of Africa CDC, Dr. Kaseya had a distinguished career, holding multiple significant roles. At the national level, Dr. Kaseya has been entrusted with significant responsibilities, contributing his expertise to the health initiatives of his home country. These roles have included serving as a Senior Adviser to President Laurent Desire Kabila at a ministerial level, where he played a vital role in shaping healthcare policies and strategies. Additionally, he has taken on roles such as the Head of Routine Immunization within the National Expanded Programme on Immunization, showcasing his dedication to enhancing healthcare delivery at the grassroots level.

 

On the international stage, he has worked with prominent organisations such as UNICEF, Gavi, CHAI, and the World Health Organization, where he has been instrumental in driving forward various health initiatives of continental significance. Dr. Kaseya is a devoted family man and a proud father of three daughters.

Anonymous ID: f136fc Aug. 16, 2024, 7:42 a.m. No.21422276   🗄️.is 🔗kun   >>2284 >>2304 >>5199 >>0018 >>5762 >>2802

>>21399001

>>21422270

>>21422273

 

“WHO declares mpox outbreaks in Africa a global health emergency as a new form of the virus spreads”

 

https://www.msn.com/en-us/health/other/who-declares-mpox-outbreaks-in-africa-a-global-health-emergency-as-a-new-form-of-the-virus-spreads/ar-AA1oQrpG

8/15/2024

 

The World Health Organization declared the mpox outbreaks in Congo and elsewhere in Africa a global emergency on Wednesday, with cases confirmed among children and adults in more than a dozen countries and a new form of the virus spreading. Few vaccine doses are available on the continent.

 

Earlier this week, the Africa Centers for Disease Control and Prevention announced that the mpox outbreaks were a public health emergency, with more than 500 deaths, and called for international help to stop the virus’ spread.

 

“This is something that should concern us all … The potential for further spread within Africa and beyond is very worrying,” said WHO director-general Tedros Adhanom Ghebreyesus.

 

“We are now in a situation where (mpox) poses a risk to many more neighbors in and around central Africa,” said Salim Abdool Karim, a South African infectious diseases expert who chairs the Africa CDC emergency group. He said the new version of mpox spreading from Congo appears to have a death rate of about 3-4%.

 

https://covid19commission.org/salim-abdool-karim

 

Caprisa Professor for Global Health in Epidemiology, Mailman School of Public Health (USA)

 

Salim S. Abdool Karim, FRS, is a South African clinical infectious diseases epidemiologist widely recognized for scientific contributions to HIV prevention and treatment. He is Director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, and CAPRISA Professor of Global Health at Columbia University, New York. He is the Chair of the South African Ministerial Advisory Committee on COVID-19.

 

He is an Adjunct Professor of Immunology and Infectious Diseases at Harvard University, Adjunct Professor of Medicine at Cornell University and Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal. He previously served as President of the South African Medical Research Council.

 

Dr. Abdool Karim is ranked among the world’s most highly cited scientists by Web of Science. He serves on the Boards of several journals, including the New England Journal of Medicine, Lancet Global Health, Lancet HIV and mBio. He is the Chair of the UNAIDS Scientific Expert Panel and the WHO’s Strategic and Technical Advisory Committee for HIV. He is a member of the WHO TB-HIV Task Force.

 

His awards include the African Union’s “Kwame Nkrumah Award” Africa’s most prestigious scientific award and the Canada Gairdner Global Health Award. He is member of the US National Academy of Medicine and the American Academy of Microbiology. He is a Fellow of the Royal Society.

Anonymous ID: f136fc Aug. 16, 2024, 7:44 a.m. No.21422284   🗄️.is 🔗kun   >>2288 >>2304 >>5762 >>2802

>>21422276

 

“Vaccine Maker Shares Soar After WHO Declares Health Emergency Over Africa Mpox Outbreak”

 

https://www.msn.com/en-us/health/other/vaccine-maker-shares-soar-after-who-declares-health-emergency-over-africa-mpox-outbreak/ar-AA1oQv81

8/15/2024

 

Shares of Danish company Bavarian Nordic jumped as much as 17% during early trading in Copenhagen on Thursday, though gains fell to around 11% as trading continued.

 

The rally extends a climb of around 12% from the day before, when the WHO joined Africa’s top public health body in declaring a growing mpox outbreak a public health emergency.

 

Bavarian Nordic is one of the only companies in the world with an approved mpox vaccine and in practice it is the only company as the shot it manufactures is the preferred choice of global health authorities by far on account of the much lower risks of negative outcomes associated with it.

 

Bavarian Nordic sells the vaccine under three brand names worldwide—Jynneos, Imvamune and Imvanex—and U.S.-traded shares of the company were up nearly a third (33%) during premarket trading early Thursday morning.

 

Shares for Maryland-based Emergent BioSolutions, which acquired smallpox vaccine ACAM2000 from French pharma giant Sanofi in 2017—smallpox is related to mpox and the shot is believed to protect against it as well—had soared nearly 12% by market close on Wednesday, though shares dipped more than 3.5% during premarket trading Thursday.

 

Tonix Pharmaceuticals, a U.S. firm with an experimental shot in early-stage trials for horsepox with the potential for further applications to smallpox and mpox, also dipped 3.6% during premarket trading, paring gains of 2.7% from the day before.

 

What Treatments Are There For Mpox?

 

There are few specific treatments approved for mpox and many have not been extensively tested on the disease given the lack of cases. Those approved for smallpox, which was eradicated in 1980, have even less data, though the similarities between the two viruses mean therapies that work for one are likely to have at least some impact on the other. While they cannot prevent infection, therapies can help save patients, reduce symptoms and disease progression and potentially lower the risk of onward transmission. Antiviral drug tecovirimat has been approved for use against smallpox based on animal tests and while not authorized to treat mpox patients in the U.S., the drug was made available for this purpose under emergency protocols during the 2022 outbreak. The drug, marketed as Tpoxx by Siga Technologies, is still undergoing testing to be approved specifically for mpox. Siga shares were up nearly 27% at market close on Wednesday and were up more than 1% in premarket trading on Thursday.

Anonymous ID: f136fc Aug. 16, 2024, 7:45 a.m. No.21422288   🗄️.is 🔗kun   >>5762 >>2802

>>21422284

>Bavarian Nordic

 

“Bavarian Nordic says it can supply 10M mpox jabs by end of 2025”

 

https://www.politico.eu/article/bavarian-nordic-says-it-can-supply-10m-mpox-jabs-by-end-of-2025/

August 15, 2024 12:41 pm CET

 

The company said it is waiting to receive orders.

 

Bavarian Nordic can provide 10 million doses of its mpox vaccine to African countries by the end of 2025 to help them deal with the latest global public health emergency, the vaccine manufacturer’s CEO said.

 

“We have inventory and we have the capabilities. What we’re missing are the orders,” Paul Chaplin told Bloomberg.

 

The Africa Centres for Disease Control and Prevention (Africa CDC) has said it needs 10 million doses to control the outbreak, which has spread from the Democratic Republic of the Congo to neighboring countries in recent weeks.

 

The Danish drugmaker and the European Commission have already donated more than 200,000 doses. Chaplin said the company has 300,000 doses ready for shipping immediately and could provide 2 million doses to Africa by the end of this year.

 

“We are in late August already, so it really does need some speed in the decision making to be able to do that,” he said.

 

Stockpiles of the vaccine are also held in other places, in preparation for future outbreaks. The European Union signed a contract for 2 million doses in November 2022 , while some countries in Europe also hold national stockpiles. The U.S. Biomedical Advanced Research and Development Authority (BARDA) this month issued an order to Bavarian Nordic to replenish its stocks of the vaccine.

 

The World Health Organization declared the mpox outbreak in Africa a public health emergency of international concern on Aug. 14. A more deadly strain of the virus, spreading among children and via sexual contact, is of particular concern, WHO officials said.

Anonymous ID: f136fc Aug. 16, 2024, 7:51 a.m. No.21422304   🗄️.is 🔗kun   >>0018 >>5762

>>21422276

>Salim Abdool Karim, a South African infectious diseases expert who chairs the Africa CDC emergency group

 

>>21398994

>>21422270

>Ebola

 

>>21422284

>Vaccine Maker Shares Soar After WHO Declares Health Emergency Over Africa Mpox Outbreak

 

“COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats”

 

https://gh.bmj.com/content/bmjgh/8/6/e011883.full.pdf

Received 29 January 2023

Accepted 9 March 2023

Authors; Peter J Hotez ,1 Sarah Gilbert,2 Melanie Saville,3 Lois Privor-Dumm ,4 Salim Abdool-Karim ,5 Didi Thompson,3 Jean-Louis Excler ,6 Jerome H Kim6

 

SUMMARY BOX

 

⇒ Based on the recent track record of successes for new Ebola and COVID-19 vaccines, accelerating next generation global health and pandemic threat vaccines will require a multidimensional approach that advances several vaccine technologies—messenger RNA, adenovirus, inactivated virus, nanoparticle and protein vaccines—simultaneously.

 

⇒ Low and middle-income country (LMIC) vaccine producers must be prioritised for financial and technical support early on, along with the multinational pharma companies.

 

⇒ These LMIC vaccine producers must be encouraged to pursue vaccines based on their existing capabilities, but also afforded opportunities to produce new technology vaccines along with support for rapid scale-up of production.

 

⇒ The system of stringent regulatory authorities must be extended to national regulatory authorities (NRAs) in Asia, Latin America and Africa.

 

⇒ Capacity building for regulatory science in LMICs is paramount.

 

⇒ A United Nations (UN) Pandemic Treaty and Group of 20 (G20) nations, especially the large middleincome G20 countries, should support LMIC vaccine producers and NRAs through better organised and funded initiatives.

 

⇒ In parallel, the UN Pandemic Treaty, G20 nations and civil societies must acknowledge the threat of rising antivaccine disinformation and its evolution into a wide-ranging and dangerous ecosystem, and seek solutions through international cooperation to combat it while maintaining or restoring trust among their populations

 

Attached is Salim Abdool Karim record which can be found at https://orcid.org/0000-0002-4986-2133 which contains employment, education, membership, service and a list of his 454 works.

Anonymous ID: f136fc Aug. 16, 2024, 8:02 a.m. No.21422340   🗄️.is 🔗kun   >>0018 >>5762 >>7168 >>6942 >>6947 >>6985

>>20971200

>>20971210

>>21398986

>>21398994

>>21399001

>>21422270

>Wellcome Trust

 

“WHO, Bill Gates and Wellcome Trust’s Global Vaccine Fund Lacks Transparency and Accountability”

 

https://expose-news.com/2022/10/11/gates-wellcome-trusts-global-vaccine-fund-lacks/

October 11, 2022

 

Working closely with the World Health Organisation (“WHO”), four global health organisations – the Bill & Melinda Gates Foundation, Gavi, The Wellcome Trust and CEPI – played a central role in creating the Access to Covid-19 Tools Accelerator (“ACT-A”). And a consortium operated by Gavi, CEPI and UNICEF named COVAX is the vaccine pillar of ACT-A.

 

Throughout the spring and summer of 2020, the four global health organisations poured money into vaccine development and lobbied governments to pour money into them and their ACT-A initiative. However, from its inception, ACT-A has lacked transparency and accountability an investigation by Politico and Welt has found.

 

https://www.politico.com/news/2022/09/14/global-covid-pandemic-response-bill-gates-partners-00053969

 

The four organizations had worked together in the past, and three of them shared a common history. The largest and most powerful was the Bill & Melinda Gates Foundation, one of the largest philanthropies in the world. Then there was Gavi, the global vaccine organization that Gates helped to found to inoculate people in low-income nations, and the Wellcome Trust, a British research foundation with a multibillion dollar endowment that had worked with the Gates Foundation in previous years. Finally, there was the Coalition for Epidemic Preparedness Innovations, or CEPI, the international vaccine research and development group that Gates and Wellcome both helped to create in 2017.

 

Gavi was founded in 1999 with $750 million from the Gates Foundation to strike vaccine deals with pharmaceutical companies for low-income countries. The vast majority of its financing is made up of donations from governments. The organization focuses solely on immunization and its board is made up of multiple representatives from the global south.

 

In July, CEPI announced it would donate $66 million to Clover Biopharmaceuticals to help the company through its clinical trials. CEPI, Wellcome and the Gates Foundation invested up to $449 million in Oxford University — including partnerships with the school and other companies — for vaccines. Wellcome granted $2.4 million to the Wits Health Consortium in South Africa to help with research on detecting and surveilling Covid.

 

Oversight and political leadership for ACT-A came through the facilitation council, a committee co-hosted by the WHO and the European Commission that included representatives from various countries, including the consortium’s co-chairs, South Africa and Norway.